Westfield Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$102M |
| 2 |
S&P Global
SPGI
|
+$82.9M |
| 3 |
Intercontinental Exchange
ICE
|
+$72.4M |
| 4 |
Nike
NKE
|
+$55.5M |
| 5 |
Avery Dennison
AVY
|
+$49.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$95.4M |
| 2 |
TJX Companies
TJX
|
+$94.8M |
| 3 |
Chubb
CB
|
+$87.2M |
| 4 |
Intel
INTC
|
+$80.1M |
| 5 |
Union Pacific
UNP
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 17.63% |
| 3 | Consumer Discretionary | 13.42% |
| 4 | Industrials | 12.91% |
| 5 | Communication Services | 12.63% |
Similar funds
Westfield Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Westfield Capital Management held 303 positions worth $11.6B, up 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management withdrew a net $770M in Q1 2017, closing 45 positions and reducing 133 holdings. Its most notable exit was TJX Companies, an estimated $94.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Biogen worth $98.2M.
- Westfield Capital Management's largest Q1 2017 buy was Biogen: 359,107 shares worth $98.2M.
- Westfield Capital Management added most to Walt Disney in Q1 2017, an estimated $48.8M increase.
- Westfield Capital Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $95.4M.
- Westfield Capital Management fully exited TJX Companies in Q1 2017, selling an estimated $94.8M.
- Westfield Capital Management's ten largest holdings make up 17% of its $11.6B portfolio in Q1 2017.
- Westfield Capital Management opened 50 new positions and closed 45 in Q1 2017.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $11.6B.
Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.